series-a
Stage
2020
Founded
1
Investors
About
Sigrid Therapeutics develops non-pharmaceutical metabolic health solutions using its patented SiPore® silica technology to slow digestion, reduce blood sugar spikes, and support weight management.
Explore Sigrid Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.